Introduction/Overview
Natural products, as an important treasure trove for drug discovery, play an irreplaceable role in the history of human disease prevention and treatment. Zingerone, also known as 4- (4-hydroxy-3-methoxyphenyl) -2-butanone, is an aromatic phenolic compound isolated from the rhizome of ginger (Zingiber officinale Roscoe) and is one of the main active ingredients in the spicy flavor of ginger. Since its structure was elucidated, gingerone has attracted much attention due to its wide range of biological activities and good safety. In traditional medicine, ginger is used to treat nausea, vomiting, inflammation, and digestive system diseases. Modern pharmacological research has gradually revealed the scientific connotations behind these effects, and gingerone, as one of its key active molecules, is becoming increasingly prominent. Studies have shown that gingerone not only has significant anti-inflammatory and antioxidant properties, but also shows great potential in anti diabetes, anti-tumor, neuroprotective and gastrointestinal regulation. Its unique advantage lies in its ability to efficiently cross the blood-brain barrier, providing the possibility for intervention in central nervous system diseases. This article aims to systematically review the chemical properties, plant sources, pharmacological activities, molecular mechanisms of action, pharmacological characteristics, and clinical application prospects of gingerone, in order to provide comprehensive scientific references for the in-depth development and transformation research of this natural product.
Chemical structure and physicochemical properties
The chemical name of gingerone is 4- (4-hydroxy-3-methoxyphenyl) -2-butanone, CAS number 122-48-5, molecular formula C11H14O3, and molecular weight 194.23 g/mol. Its structure can be regarded as a derivative of Vanillin, hence it is also known as Vanillyl acetone. Its core structure consists of a benzene ring with hydroxyl (- OH) and methoxy (- OCH3) substituents attached, and a four carbon ketone chain (- CH2CH2COCH3) as the side chain. This structure makes it both hydrophilic and lipophilic.
The key physicochemical property parameters are as follows: the calculated lipid water partition coefficient (LogP) is about 1.90, indicating that it has moderate lipophilicity and is conducive to transmembrane transport. The topologically polar surface area (TPSA) is 46.53 Å ², which is relatively small and further supports its good membrane permeability. The water solubility is about 1.33 mg/mL, belonging to the range of slightly soluble to soluble, which provides a basis for its absorption and distribution in organisms. The most prominent property is its high penetration ability into the blood-brain barrier (BBB), which is closely related to its moderate molecular weight, LogP value, and TPSA value, laying the physical and chemical foundation for its central nervous system activity. In addition, preliminary pharmacological screening showed that gingerone had no significant inhibitory effect on hERG potassium channels in vitro (indicating low potential risk of cardiac toxicity), and the Ames test result was negative (0.0), indicating that it had no mutagenicity and good safety characteristics.
Plant sources and extraction methods
Ginger ketone mainly comes from the rhizome of Zingiber officinale Roscoe, a plant in the ginger family. Ginger, as a plant with medicinal and edible properties, has complex active ingredients, mainly including gingerols (such as gingerol and gingerol), gingerones, volatile oils, etc. Ginger ketone is not the main pungent component in ginger. It is often considered a degradation product of gingerol compounds that undergo reverse aldol condensation reactions during heating, drying, or long-term storage. Therefore, its content is relatively high in dried ginger or cooked ginger products.
There are various methods for extracting gingerone from ginger, aiming to efficiently and environmentally obtain high-purity compounds. Traditional methods include solvent extraction, which often involves refluxing or leaching with organic solvents such as ethanol, methanol, or acetone, followed by separation and purification using techniques such as silica gel column chromatography and high-performance liquid chromatography (HPLC). With the advancement of technology, modern extraction methods such as supercritical fluid extraction (SFE, commonly using CO2 as the medium), ultrasound assisted extraction, and microwave-assisted extraction have been applied. These methods can shorten extraction time, improve extraction efficiency, reduce the amount of organic solvents used, and better protect thermosensitive components. The optimization of extraction processes usually focuses on factors such as solvent type, concentration, temperature, time, and solid-liquid ratio. Identification and quantitative analysis are often carried out using gas chromatography-mass spectrometry (GC-MS) or high-performance liquid chromatography-mass spectrometry (HPLC-MS) techniques.
Pharmacological activity research
A large number of in vitro and in vivo studies have confirmed that gingerone has diverse pharmacological activities, and its effects are not limited to the traditional "warming the middle and dispersing the cold".
-
Anti inflammatory and antioxidant activity This is one of the core activities of gingerone. In various acute and chronic inflammation models, such as carrageenan induced paw edema in rats and lipopolysaccharide induced macrophage inflammation model, gingerol can significantly inhibit the redness, swelling, heat and pain at the inflammatory site, and reduce the level of inflammatory mediators. Its antioxidant effect is manifested by effectively clearing free radicals such as DPPH and ABTS, enhancing the activity of endogenous antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT), and reducing the levels of lipid peroxidation products such as malondialdehyde (MDA), thereby alleviating oxidative stress.
-
Antitumor activity: Ginger ketone has shown inhibitory potential on a variety of cancer cells, including colon cancer, breast cancer, liver cancer and neuroblastoma. Its functions include inhibiting cancer cell proliferation, inducing cell cycle arrest (such as G1 phase arrest), promoting cancer cell apoptosis, and inhibiting migration and invasion. For example, studies have shown that gingerone can act as an anti mitotic agent, specifically inhibiting the growth of neuroblastoma.
-
Anti diabetes and metabolic regulation activity In the animal model of diabetes, gingerone can reduce fasting blood glucose, improve glucose tolerance and increase insulin sensitivity. Its mechanism involves protecting pancreatic beta cells, inhibiting intestinal alpha glucosidase activity to reduce glucose absorption, and regulating key enzymes and signaling pathways related to glucose and lipid metabolism. Its "anti lipid allergy" activity also refers to its ability to improve blood lipid disorders, reduce serum total cholesterol, triglycerides, and low-density lipoprotein levels.
-
Gastrointestinal protective activity Ginger ketone has anti diarrheal and anti spasmodic effects. It can inhibit excessive peristalsis of the gastrointestinal tract and combat diarrhea caused by chemicals such as castor oil, magnesium sulfate, or bacterial toxins. Its antispasmodic effect may be related to the regulation of calcium ion channels or certain receptors in intestinal smooth muscle.
-
Neuroprotective activity Thanks to its excellent BBB penetration ability, gingerone has shown protective effects in central nervous system disease models. Research suggests that it has an improvement effect on models of Alzheimer's disease, Parkinson's disease, cerebral ischemia-reperfusion injury, and epilepsy, mainly through its anti-inflammatory and antioxidant properties, as well as regulating neurotransmitters and neurotrophic factors.
Mechanism of action and molecular targets
The pleiotropic pharmacological effects of gingerone stem from its regulation of multiple key signaling pathways and molecular targets, with the core of its action network being the inhibition of inflammation and survival signals mediated by nuclear factor kappa B (NF - κ B).
-
Core pathway: NF - κ B signaling pathway Ginger ketone can effectively inhibit the activation of NF - κ B. It downregulates the expression of a series of pro-inflammatory cytokines and enzymes by preventing the phosphorylation and degradation of I κ B α (an inhibitory protein of NF - κ B), or inhibiting the translocation of NF - κ B subunit p65 to the nucleus. This is one of the main mechanisms of its anti-inflammatory and anti-tumor effects.
-
Key molecular targets：
- Pro-inflammatory mediators Ginger ketone can significantly downregulate the expression of key pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor - α (TNF - α). At the same time, it inhibits the activity of inducible nitric oxide synthase (NOS2) and cyclooxygenase-2 (PTGS2/COX-2), reducing the production of inflammatory mediators such as nitric oxide (NO) and prostaglandin E2 (PGE2).
- Inflammation related signaling nodes Ginger ketone can inhibit the phosphorylation and activation of signal transduction and transcription activator 3 (STAT3), which is closely related to inflammation, cell proliferation, and tumorigenesis. In addition, it can also inhibit the activation of NLRP3 inflammasome, manifested as the inhibition of caspase-1 (CASP1) activity, thereby reducing the maturation and release of inflammatory factors such as IL-1 β.
- Ion channels and receptors Ginger ketone is a regulator of transient receptor potential vanillic acid subtype 1 (TRPV1) and transient receptor potential anchor protein subtype 1 (TRPA1). It exhibits excitatory/desensitizing effects on TRPV1, which may be related to its initial warmth sensation and subsequent analgesic and anti-inflammatory effects. The regulation of TRPA1 is involved in its gastrointestinal spasmolytic and neuroprotective effects.
- Cyclooxygenase-1 (PTGS1/COX-1)Compared with selective inhibition of COX-2, gingerone has relatively weaker inhibition of COX-1, which helps to reduce the risk of side effects on gastrointestinal mucosa while exerting anti-inflammatory effects.
-
Antioxidant defense system Ginger ketone upregulates the expression of phase II detoxifying enzymes and antioxidant proteins such as heme oxygenase-1 (HO-1) and quinone oxidoreductase 1 (NQO1) by activating the nuclear factor E2 related factor 2 (Nrf2) pathway, thereby enhancing the antioxidant defense ability of cells.
In summary, gingerone exerts synergistic anti-inflammatory, antioxidant, anti proliferative, and cell protective effects through multiple targets and pathways.
Evaluation of drug properties and pharmacokinetics
Based on its good physicochemical properties and preliminary safety data, gingerone exhibits positive potential for drug development.
-
Absorption, Distribution, Metabolism, and Excretion (ADME)：
- absorb Ginger ketone can be effectively absorbed in the gastrointestinal tract after oral administration. Its moderate LogP value and molecular weight are conducive to passive diffusion.
- distribution Pharmacokinetic studies have shown that after oral administration, gingerone can quickly enter the systemic circulation and be widely distributed in various tissues. Its most significant advantage is the ability to efficiently cross the blood-brain barrier and achieve effective concentration in the central nervous system, which is a prerequisite for its neuroprotective effect.
- Metabolism Ginger ketone mainly undergoes II phase binding reactions in the body, such as glucuronidation and sulfation, to form corresponding complexes. The hydroxyl group on its benzene ring is the main site for metabolic modification. In addition, side chains may also undergo reactions such as reduction or β - oxidation.
- excretion Metabolites are mainly excreted from the body through urine. The elimination half-life of gingerone prototype and its metabolites is relatively short, suggesting that multiple administrations may be necessary to maintain stable blood drug concentrations.
-
safety evaluation Current research generally suggests that gingerone has low toxicity. As a natural ingredient of ginger, its long-term consumption history has proven its safety. Systematic toxicology studies have shown that even higher doses of gingerone did not cause significant organ toxicity or death in experimental animals. Its absence of hERG inhibition and Ames mutagenicity negative results further supports its good safety window.
-
Drug Challenge Despite the promising prospects, the development of ginger ketone as a drug still faces challenges. Its oral bioavailability needs to be accurately quantified and may be further improved through pharmaceutical methods such as nano formulations and phospholipid complexes; The metabolic rate in the body is relatively fast, and structural modifications may be needed to prolong its action time; As a multi-target compound, its mechanism of action is complex and requires further research to clarify its main therapeutic targets and potential off target effects for specific diseases.
Clinical application prospects and prospects
The diverse biological activities of gingerone provide broad prospects for its application in multiple therapeutic fields.
-
Potential therapeutic areas：
- Inflammatory diseases Can be used as an adjuvant therapy for chronic inflammatory diseases such as rheumatoid arthritis, inflammatory bowel disease (such as ulcerative colitis), asthma, etc., as a supplement or alternative to existing anti-inflammatory drugs, especially suitable for patients who need long-term medication and are concerned about the side effects of traditional nonsteroidal anti-inflammatory drugs or hormones.
- Metabolic diseases As an auxiliary therapeutic agent for type 2 diabetes and metabolic syndrome, it plays a role by improving glucose and lipid metabolism and reducing insulin resistance.
- Neurological disorders Its BBB penetration ability makes it highly attractive for the treatment of Alzheimer's disease, Parkinson's disease, neuroprotection after stroke, multiple sclerosis, and even depression. It can be developed as a neuroprotective agent or adjuvant therapy drug.
- neoadjuvant therapy Can be used as a chemopreventive agent or in combination with conventional chemotherapy/radiotherapy to enhance efficacy and reduce side effects (such as chemotherapy-induced nausea, vomiting, or neurotoxicity).
- Gastrointestinal dysfunction Used for treating functional diarrhea, irritable bowel syndrome (diarrhea type), and gastrointestinal spasms.
-
Development Strategy and Prospects：
- structural optimization By chemically modifying the ginger ketone core, such as introducing different functional groups or synthesizing derivatives, the aim is to improve its activity, selectivity, metabolic stability, and oral bioavailability.
- New delivery system Develop novel drug delivery systems such as liposomes, nanoparticles, microemulsions, or transdermal patches to improve their solubility, targeting, controlled release, and enhance BBB penetration efficiency.
- In depth mechanism research Using omics techniques (proteomics, metabolomics) and gene editing tools to more accurately depict the network of action and direct targets of gingerone in specific disease models.
- Clinical translational research Current research mostly remains in the preclinical stage. There is an urgent need to design rigorous randomized controlled clinical trials to evaluate the safety, efficacy, and optimal dosing regimen of gingerone or its optimized products in humans, in order to promote their transition from the laboratory to the market.
Conclusion
Ginger ketone, as a natural phenolic compound derived from ginger, has become a star molecule in natural product pharmacology research due to its wide pharmacological activity, multi-target mechanism of action, excellent blood-brain barrier penetration ability, and good safety. From inhibiting the core pathway of NF - κ B inflammation to regulating various cytokines, enzymes, and ion channels, gingerone has demonstrated the potential to respond to complex disease networks, especially in the fields of chronic inflammation, metabolic disorders, neurodegenerative diseases, and tumor prevention and treatment. Although there are still challenges in terms of bioavailability and metabolic stability in drug development, these obstacles are expected to be overcome through the intervention of modern medicinal chemistry, pharmacology, and systems biology methods. In the future, with the continuous deepening of basic research and steady progress in clinical translation, gingerone and its derivatives are expected to transform from traditional seasoning ingredients into modern drugs with clear therapeutic value, contributing the wisdom and power derived from nature to the cause of human health.
